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Among the  components of the  azurophil or pri- 
mary granules of the human neutrophilic polymor- 
phonuclear  leukocyte  (PMN)'  are  myeloperoxi- 
dase  (MPO),  neutral proteases, acid hydrolases, 
and a group of strongly cationic proteins. Some of 
these  granule  constituents participate in  the  mi- 
crobicidal  activity  of  the  PMN  (for  review  see 
reference  21).  Myeloperoxidase has  potent  anti- 
microbial activity when combined with H202 and a 
halide cofactor (18-21, 23, 25). Cationic proteins 
which  are present  in  large amounts  in  the  PMN 
granules of some  species also  have  microbicidal 
activity (24, 26, 27, 35, 36). A number of electro- 
phoretically  distinct  granular  cationic  proteins 
have  been  isolated  in  high  purity  from  human 
PMNs by Olsson  and  Venge  (29)  and shown  to 
have bactericidal activity againt a variety of micro- 
organisms (26, 27). These proteins also have chy- 
motrypsin-like esterase activity (27, 32), although 
this appears to be unrelated to bactericidal capac- 
ity since heating destroys enzymatic, but not mi- 
crobicidal activity (26, 27). 
PMN granule components gain direct access to 
ingested micro-organisms by fusion of the granule 
membrane with the phagocytic vacuole, rupture of 
the  connecting  membrane,  and  discharge of the 
microbicidal agents  into  the  vacuole  (1,  2,  20). 
Extracellular  release  of granule  constituents  in- 
cluding MPO  (1, 4,  13,  14,  17) and cationic pro- 
teins (31) also occurs. This secretory activity may 
' Abbreviations  used in this paper:  cpm, counts per min- 
ute; MPO, myeloperoxidase;  PMN, polymorphonuclear 
leukocyte. 
be initiated by particle ingestion (1,4, 10, 12-14, 
16, 17, 3], 34), contact of the PMN with immune 
complexes on  a  noningestible membrane  surface 
(10,  12-14), contact with biologically active com- 
plement fragments such as C5a (3), or exposure of 
cytochalasin B-treated PMNs to particles or C5a 
(9,  11,  15, 37). 
Extracellular  release  of  granule  constituents 
raises the possibility of PMN-mediated tissue dam- 
age. Recent attention has focused on the potential 
role of peroxidases in the destruction of both nor- 
mal (6, 22, 33) and neoplastic (4-6, 30) mamma- 
lian cells. A cytotoxic effect of MPO, H202, and a 
halide on mammalian tumor cells has been dem- 
onstrated  (5,  6),  and  we  have  recently  docu- 
mented a role for the myeloperoxidase system in 
the killing of tumor cells by intact human PMNs in 
vitro  (4).  In  the  latter  studies,  phagocytosing 
PMNs released MPO  and H202  which combined 
with  extracellular  halides  to  damage  the  target 
cells. Killing of antibody-coated neoplastic cells by 
human PMNs has also been demonstrated (7, 8), 
although a potential role for granule constituents 
in mediating this effect has not been evaluated. In 
the current report, highly purified human granular 
cationic proteins are  shown  to  have  a  cytotoxic 
effect on mammalian tumor cells. 
MATERIALS  AND  METHODS 
Cationic proteins were purified from human  PMNs ob- 
tained from a patient with chronic myeloid leukemia as 
previously described  (29).  A lyopbilized fraction desig- 
nated cationic protein A consisting of a mixture of pro- 
teins 1 and 2 (26, 27, 29) and another lyophilized frac- 
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where cpm of 5~Cr are determined in supernates from 
experimental  samples  (sample  cpm),  control  tubes 
(control cpm, see figure legends), and tubes containing 
1% Triton X-100 (max cpm, see reference 5). 
Histone (type 11, calf thymus) and protamine sulfate 
were obtained from  Sigma Chemical Co.,  St.  Louis, 
Mo. Preservative-free heparin sodium (146 U/mg) was 
obtained from Connaught Medical Research Laborato- 
ries, Toronto, Canada. Standard error is used through- 
out  as  an  estimate of variance, and  means are  com- 
pared using the t-test. 
RESULTS 
Cationic  Protein B 
Fig.  1 illustrates the effect of various concen- 
trations of human granule cationic protein B  on 
LSTRA tumor cells employing a  2-h incubation 
period.  A  significant  cytotoxic  effect  was  ob- 
served  at  25  /zg/ml  (9.6%  -  2.3,  n  =  5,  P  < 
0.02,  t-test),  although  5'Cr  release  was  more 
striking at 50/xg/ml (45.9%  -  8.4, n  =  11, P  < 
0.001). Fig. 2 shows the dependence of the cyto- 
toxic effect on  the  time  of exposure to  granule 
cationic  proteins.  Also  depicted  in  Fig.  2  is  a 
comparison  of  the  cytotoxic effects of cationic 
protein B  and MPO from the same PMNs. MPO 
was used  in  the  presence of H202  and  chloride 
since  previous  studies  had  demonstrated  a  re- 
quirement for each of these components for cyto- 
toxic activity  (5).  No  cytotoxicity was observed 
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FIGURE  1  Cytotoxic effect of human granule  cationic 
protein B on LSTRA cells. The complete reaction mix- 
ture contained 0.07 M sodium phosphate buffer, pH 7.0; 
1.5  x  10 -3  M  KH2PO4; 1.5  x  10  :~  M  MgSO4; 105 
LSTRA cells (mean 4,700 cpm 5'Cr);  and cationic pro- 
tein B, 0 (control tubes)-100/~g/ml. Total volume was 
0.5  ml.  Incubations were  performed in  10  x  75-mm 
glass  test tubes for 2  h  in  a  37~  water bath  shaker 
agitating  60 times per minute. Results  are expressed as 
mean percent (-+SE) 51Cr release. 
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Kinetics of the cytotoxic  effect of granular 
tion designated cationic protein B consisting of a mixture 
of proteins 3  and  4  (26,  27,  29)  were  suspended in 
distilled  water at 500  p.g/ml and stored at  -70~  until 
just before use. Purified myeloperoxidase from the same 
cell  preparation  (28)  was  used  in  some  experiments; 
lyophilized MPO was suspended in distilled water at 250 
p,g/ml and stored at  -20~ 
The  target  cell  employed was  a  well-ch'aracterized 
Moloney  virus-induced  lymphoma  of  BALB/c  origin 
designated LSTRA and maintained by serial intraperito- 
neal passage in  BALB/c mice  (5).  LSTRA cells  were 
harvested  from  ascites  fluid,  labeled  with  51Cr  (so- 
dium[51Cr]chromate,  200-500/zCi/p.g Cr, New England 
Nuclear, Boston, Mass.), washed, and suspended in 0.1 
M sodium phosphate buffer, pH 7.0, as previously  de- 
scribed (5). Labeled target cells were incubated with the 
components of the cytotoxicity  system (see legends to 
figures), and the cytotoxic effect was determined as the 
mean  release  of 5'Cr  in  duplicate  samples.  Data  are 
expressed as a  percent of maximum releasable activity 
(5)  as follows: 
cationic protein B and myeloperoxidase. The conditions 
for testing cationic  proteins were the same as described 
in  Fig.  1,  except  that  a  constant  amount  of cationic 
protein B (50 gg/ml) was employed. The myeloperoxi- 
dase  system  consisted  of  0.03  M  sodium  phosphate 
buffer, pH 7.0; KH2PO4, MgSO4, and LSTRA cells as in 
Fig.  1; MPO 5  gg/ml (enzyme activity  24  mU/ml [see 
reference 4]);  H202 5  X 10 -5 M and NaC1 0.1  M. The 
incubation period was varied as indicated. Mean percent 
5JCr release in 9 experiments with MPO and 4-11 exper- 
iments with cationic proteins is shown. 
with H202  and chloride in the absence of MPO. 
Even though  the  amount of MPO  employed (5 
/zg/ml) was 10 %  the amount of cationic proteins, 
comparable cytotoxic activity was observed in the 
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Effects of Heating, Ionic Strength, and Heparin 
Conditions* 
Cytotoxicity  (5~Cr percent  release) 
Cationic  protein B  Cationic  protein A (Lot I )  Cationic  protein A (Lot 2) 
Complete system 
Cationic protein heatedw 
Ionic strength decreased U 
Ionic strength increased U 
Heparin added (30 /zg/ml) 
45.9  _+ 8.4 (11):~ 
78.9 _+ 9.3 (4) 
47.0  +  2.9 (2) 
40.4  -+ 2.9 (2) 
0.0 +- 0.0 (2) 
93.1  m 6.9  (3)  3.8 m 3.8 (5) 
82.4 m 17.6 (2)  68.3 -+ 1.7 (3) 
100.0 •  0.0  (2)  31.2 -+ 7.4 (2) 
100.0 -  0.0  (2)  0.0  (1) 
1.8  •  1.8  (2) 
* Conditions as specified in Fig. 1 (cationic protein 50 /xg/ml) with alterations as noted. 
;t Mean +_ SE, number of experiments in parentheses. 
w  90~  for 10 min. 
H  Ionic strength altered by employing phosphate buffer at 0.05 M (decreased) or 0.10 M (increased) in place of the 
usual 0.07 M concentration. 
two  systems.  Although the  MPO  system had  a 
more rapid initial rate of activity and a lower final 
activity relative  to  the  cationic proteins,  these 
differences were  not  significant. Since cationic 
protein B at  10 /.Lg/ml or less had no significant 
effect, the data suggest that MPO in the presence 
of H202 and chloride constitutes a  more potent 
cytotoxic system  than  the  granule cationic pro- 
teins. 
The cytotoxic effect of cationic protein B was 
not diminished by heating at 90~  for 10 rain. In 
fact, with the conditions employed (50 /xg/ml of 
cationic protein B, 2-h incubation period), signif- 
icant  enhancement  (P  <  0.05)  was  observed 
(Table  I).  Changing  the  ionic  strength  in  the 
cytotoxicity assay  by  using 0.05  M  and  0.1  M 
phosphate  buffer in place  of the  usual 0.07  M 
concentration (see figure legends) had no signifi- 
cant effect on the activity of cationic protein B 
(Table I). 
Cationic Protein A 
Two  separate  lots of cationic protein A  from 
PMNs of two different patients were studied (Ta- 
ble I). Lot  1 was highly potent with a mean ~lCr 
release of 93.1% -  6.9 in three experiments (P < 
0.01) using 50/xg/ml and a 2 h incubation period. 
At  25,  10,  and  5  /xg/ml  51Cr release  was  39.8, 
16.8, and 2.6%, respectively. With the same con- 
ditions, lot  2  was  markedly inferior in cytotoxic 
activity (mean 3.8% 5tCr release with 50/xg/ml in 
five  experiments). Similar differences in bacteri- 
cidal and esterase activities of these two prepara- 
tions were also observed3 Heating at 90~  for 10 
min had no significant effect on the more potent 
Olsson, I. Unpublished observations. 
preparation (Table I). Heating the weaker prepa- 
ration resulted in a significant increase in cytotoxic 
activity to a mean of 68.3% (P <  0.001, Table I). 
It was also possible to detect activity in the weaker 
cationic protein A  preparation by decreasing the 
ionic strength  (mean 31.2%  with 0.05  M  phos- 
phate buffer, P  <  0.02, Table I). This latter find- 
ing  may  parallel  the  inverse  relationship noted 
between ionic strength and bactericidal activity of 
the granule cationic proteins (26). 
Heparin,  Histone,  and Protarnine 
Heparin, a  strongly anionic agent, inhibits the 
bactericidal activity of  the  granule cationic pro- 
teins  (35).  In  the  current  studies  30  /xg/ml  of 
heparin completely inhibited the cytotoxic effect 
of 50 /zg/ml of cationic protein (Table I). Incom- 
plete  inhibition was  observed  with  6  gg/ml  of 
heparin. These  concentrations of  heparin alone 
had no detectable effect on the target cells. His- 
tone and protamine, as examples of other strongly 
basic proteins, were also tested for cytotoxic activ- 
ity. Histone was very potent, with 10/zg/ml giving 
66.8% +- 10.0 51Cr release (P <  0.01); protamine 
was less active, with 25/xg/ml giving 22.9% -- 7.2 
~Cr release  (P  <  0.05).  The cytotoxic effect  of 
both  histone  and  protamine  was  unaffected  by 
heating  (90~  for  10  min),  was  completely  in- 
hibited by  heparin  (30  txg/ml), and was  dimin- 
ished  approximately 50%  by  an increase in os- 
motic strength from 0.07 M to 0.10 M phosphate. 
DISCUSSION 
The data presented document the ability of cati- 
onic proteins from granules of human PMNs to kill 
mammalian tumor  cells  as  measured  by  a  51Cr 
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concentration dependent.  The reasons for the dif- 
ferences in cytotoxic, bactericidal,  and  enzymatic 
activity between the two cationic protein A  prepa- 
rations are unknown. The quantities or properties 
of  these  granule  constituents  may  differ  in  the 
PMN  preparations  from  two  different  chronic 
myeloid  leukemia  patients.  Similar  studies  are 
planned for the basic proteins which are currently 
being purified from the PMNs of normal subjects. 
The mechanism of the cytotoxic activity of gran- 
ule cationic proteins  has  been partially character- 
ized. It does not depend on the esterase activity of 
these  proteins  since  heating  at  90~  for  10  min 
destroys  this  enzymatic  activity  (26,  27)  but  did 
not  decrease  cytotoxicity.  Heating,  in  fact,  en- 
hanced the cytotoxic activity. A  similar enhancing 
effect of heating has been reported for the bacteri- 
cidal  effect  of  human  granule  cationic  proteins 
(27). The presence of a heat-labile inhibitor in the 
cationic protein  preparations  cannot be excluded. 
The anionic agent heparin, an inhibitor of cationic 
protein  bactericidal  activity  (35),  completely 
blocked  the  cytotoxic  effect  as  well.  Thus,  the 
cytotoxic and  bactericidal  activities of these  pro- 
teins may share common mechanisms.  It is proba- 
ble  that  binding  of the  highly positively charged 
molecules to the negatively charged cell surface is 
an important  initial step. The cytotoxic activity of 
the other basic proteins tested, histone and prota- 
mine, is consistent with an ionic interaction of this 
type. 
The current studies also extend our earlier work 
on  the  cytotoxic effect of a  system  comprised  of 
canine  MPO,  H~O2,  and  a  halide  (5)  to  human 
MPO  (also  see  reference  6).  Thus,  at  least  two 
microbicidal systems of the human PMN are capa- 
ble  of  killing  mammalian  tumor  cells.  Although 
the  myeloperoxidase  system  has  been  implicated 
in the cytotoxic effect of phagocytosing PMNs (4), 
further studies will be required to assess the role of 
granule  cationic proteins  in the extracellular kill- 
ing of tumor cells by intact  neutrophils. 
SUMMARY 
Cationic  proteins  purified  from  human  polymor- 
phonuclear  leukocyte  granules  exert  a  cytotoxic 
effect  on  mammalian  tumor  cells.  This  effect  is 
time and concentration dependent,  is inhibited by 
the  anionic  agent  heparin,  and  is  enhanced  by 
preheating  the  cationic  proteins.  Other  strongly 
basic proteins (histone,  protamine)  also exhibited 
cytotoxic activity. Myeloperoxidase  isolated from 
human  leukocytes  is  cytotoxic  when  combined 
with H202  and chloride.  Under these conditions, 
the potency of the myeloperoxidase-mediated sys- 
tem is greater than that of the cationic proteins. 
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